PROVENZANO, CLAUDIA
 Distribuzione geografica
Continente #
AS - Asia 22
NA - Nord America 16
EU - Europa 10
Totale 48
Nazione #
SG - Singapore 17
US - Stati Uniti d'America 16
IT - Italia 7
KR - Corea 5
DK - Danimarca 2
AT - Austria 1
Totale 48
Città #
Singapore 17
Santa Clara 6
Rome 5
Seoul 5
Aarhus 2
Milan 2
Springfield 1
Vienna 1
Totale 39
Nome #
Gene Therapy Strategies For Myotonic Dystrophy Type 1 17
High-throughput analysis of the RNAinduced silencing complex in myotonic dystrophy type 1 patients identifies the dysregulation of miR-29c and its target ASB2 16
CRISPR/Cas9-MediatedDeletion ofCTGExpansions Recovers Normal Phenotype in Myogenic Cells Derived from Myotonic Dystrophy 1 Patients 10
Circular RNA role in Myotonic Dystrophy type 1 4
GENE EDITING IN MYOTONIC DYSTROPHY TYPE 1: ASSESSMENT OF EFFICIENCY, SAFETY AND THERAPEUTIC EFFECT OF CTG-REPEAT DELETION IN A MOUSE MODEL OF DISEASE 4
GENE EDITING IN MYOTONIC DYSTROPHY TYPE 1: ASSESSMENT OF EFFICIENCY, SAFETY AND THERAPEUTIC EFFECT OF CTG-REPEAT DELETION IN A MOUSE MODEL OF DISEASE 3
MiR-21 is an Ngf-modulated MicroRNA That supports Ngf signaling and regulates neuronal degeneration in PC12 cells 3
Application of CRISPR/Cas9 strategy for gene therapy of Myotonic Dystrophy type 1 2
Does the term 'trophic' actually mean anti-amyloidogenic? The case of NGF 2
Inducible CRISPR/Cas9 strategy mediates efficient gene editing of trinucleotide repeat expansion in DMPK locus 2
Study of pathogenetic mechanisms and development of new therapeutic strategies for Myotonic Dystrophy type 1 2
MicroRNA-222 regulates muscle alternative splicing through Rbm24 during differentiation of skeletal muscle cells 2
Design of novel small molecule base-pair recognizers of toxic CUG RNA transcripts characteristics of DM1 2
Molecular Therapies for Myotonic Dystrophy Type 1: From Small Drugs to Gene Editing 2
Eps8, a tyrosine kinase substrate, is recruited to the cell cortex and dynamic F-actin upon cytoskeleton remodeling. 1
Maintenance of the differentiated state in skeletal muscle: activation of v-Src disrupts sarcomeres in quail myotubes 1
Large scale analysis of transcription factor TTF-1/NKX2.1 target genes in GnRH secreting cell line GT1-7 1
Time-controlled and muscle-specific CRISPR/Cas9 mediated deletion of CTG-repeat expansion in the DMPK gene 1
Regulation of the tyrosine kinase substrate Eps8 expression by growth factors, v-Src and terminal differentiation. 1
BEHAVIOURAL ABNORMALITIES IN DMSXL MICE, A MODEL OF MYOTONIC DYSTROPHY TYPE 1 1
Retinoblastoma protein acts as Pax 8 transcriptional coactivator. 1
Functional characterization of a novel mutations in TITF-1 in a patient with Benign Hereditary Chorea. 1
v-Src inhibits myogenic differentiation by interfering with the regulatory network of muscle-specific transcriptional activators at multiple levels 1
Totale 80
Categoria #
all - tutte 483
article - articoli 304
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 787


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202436 0 0 0 0 0 0 0 0 0 0 9 27
2024/202544 8 3 33 0 0 0 0 0 0 0 0 0
Totale 80